**Core Concept**
The patient's presentation of upper gastrointestinal bleeding with mild splenomegaly suggests a possible diagnosis of portal hypertension, which is often secondary to liver cirrhosis. The spleen becomes enlarged due to increased blood flow and portal pressure.

**Why the Correct Answer is Right**
The most appropriate therapeutic modality in this scenario would be **vasopressin** or its analogues, such as terlipressin, to reduce portal pressure and control bleeding. This is achieved by causing vasoconstriction of the splanchnic vessels, thereby reducing blood flow to the gastrointestinal tract and decreasing bleeding. Vasopressin also has a beneficial effect on the liver by increasing hepatic vascular resistance.

**Why Each Wrong Option is Incorrect**
* **Option A:** Octreotide, a somatostatin analogue, can also reduce portal pressure and is used to control bleeding in certain cases. However, it is not the first-line treatment in this scenario.
* **Option B:** Endoscopic therapy, such as variceal ligation or sclerotherapy, is an essential treatment for upper gastrointestinal bleeding due to varices. However, it is not the most appropriate initial therapeutic modality in this scenario.
* **Option D:** Transjugular intrahepatic portosystemic shunt (TIPS) is a procedure used to reduce portal pressure by creating a shunt between the hepatic vein and a branch of the portal vein. It is typically reserved for cases of refractory bleeding or when endoscopic therapy is not feasible.

**Clinical Pearl / High-Yield Fact**
In patients with portal hypertension, the presence of mild splenomegaly can be an important clue, indicating increased portal pressure. Always consider liver cirrhosis as a possible underlying cause in patients with portal hypertension.

**Correct Answer: C. Vasopressin**